You are here

Urovant Sciences

Biopharma Layoff Tracker 2023: Rain Oncology, Takeda, PTC and more cut staff

BioSpace

Wed, 05/31/23 - 11:15 am

PTC Therapeutics

Urovant Sciences

Bristol Myers Squibb

ADC Therapeutics

Sunovion takes Urovant's overactive bladder med Gemtesa to primary care docs as promo partnership launches

Fierce Pharma

Tue, 07/13/21 - 10:59 am

Urovant Sciences

overactive bladder

FDA sets Dec. PDUFA date for Urovant rival to Astellas drug

Fierce Biotech

Fri, 03/6/20 - 10:42 am

Urovant Sciences

overactive bladder

Urovant's overactive bladder drug scores in mid-stage trial

Endpoints

Thu, 11/1/18 - 11:32 am

Urovant Sciences

overactive bladder

clinical trials

Nasdaq triple IPO play brings in $345M as the big biotech party rocks on

Endpoints

Thu, 09/27/18 - 11:55 am

Urovant Sciences

Sutro BioPharma

Urovant seeks $150M IPO just a year after launch

Fierce Biotech

Mon, 07/16/18 - 10:16 pm

Urovant Sciences

overactive bladder